ROVER GROUP, INC. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020
Assets
Current assets
Cash and cash equivalents
Prepaid expenses
Short-term investments
Accounts receivable, net
Notes receivable from related parties
Prepaid expenses and other current assets
Total current assets
Investments held in Trust Account
Restricted cash
Property and equipment, net
Operating lease right-of-use assets
Intangible assets, net
Goodwill
Deferred tax asset, net
Long-term investments
Investment in equity securities in related parties
Other noncurrent assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable
Accrued compensation and related expenses
Accrued expenses and other current liabilities
Due to related party
Franchise tax payable
Deferred revenue
Pet parent deposits
Pet care provider liabilities
Debt, current portion
Operating lease liabilities, current portion
Total current liabilities
Deferred underwriting commissions in connection with the initial public offering
Deferred underwriting commissions
Deferred underwriting commissions
Deferred rent, net of current portion
Debt, net of current portion
Operating lease liabilities, net of current portion
Earnout liabilities
Derivative warrant liabilities
Other noncurrent liabilities
Total liabilities
Redeemable convertible preferred stock, $0.00001 par value, no shares and 87,611 authorized as of December 31, 2021 and 2020, respectively; no shares and 90,814 shares issued and outstanding as of December 31, 2021 and 2020, respectively; aggregate liquidation preference of $294,802 as of December 31, 2020
Stockholders’ equity:
Preferred stock, $0.0001 par value, 10,000 shares authorized as of September 30, 2023 and December 31, 2022; no shares issued and outstanding as of September 30, 2023 and December 31, 2022
Class A common stock, $0.0001 par value, 990,000 shares authorized as of September 30, 2023 and December 31, 2022; 180,836 and 184,526 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively
Class A Common Stock
Class B Common Stock
Total class A common stock, $0.0001 par value, 990,000 shares authorized as of September 30, 2023 and December 31, 2022; 180,836 and 184,526 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Class A Common Stock
Class B Common Stock
Total stockholders’ equity
Total liabilities and stockholders’ equity
Preferred stock, shares authorized (in shares)
Common stock, shares authorized (in shares)
Class A Common Stock
Class B Common Stock
Total common stock, shares authorized (in shares)

Comments